BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%

Product NDC
72934-1028
11-digit product format
729341028
Labeler code
72934
Product ID
72934-1028_88f00580-a0ca-168f-e053-2a95a90a6e4b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%
Dosage form
GEL
Route
TOPICAL
Labeler
Sincerus Florida, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2019-05-16
Marketing end
0000-00-00
Substance
BRIMONIDINE TARTRATE; METRONIDAZOLE; NIACINAMIDE; IVERMECTIN
Active strength
0 g/100g; g/100g; g/100g; g/100g
Pharmacologic classes
Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS],Antiparasitic [EPC],Pediculicide [EPC]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6c0c444-a6ba-2fb5-a7bc-7f0443fa5791Product name420251208
8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55Product name520251024
8ec6541e-9842-115f-62bf-f7c9ab3aeddbProduct name320250805
7f6d14e0-4366-41bc-a4a9-b74c79a20e17Product name120250623
7fd951fe-040a-0b64-2bea-eefc6aa4fc54Product name220250515
e6d321b0-0e5e-7da6-f043-92b6a91f00a1Product name520250515
e1aac33b-94ae-4ee9-905b-299f7263853bProduct name320250124
39b7fcf4-8865-6d40-d24d-9b8c28bd6345Product name520250123
16642716-d28a-4f90-8dcb-3921cd8c8109Product name420240516
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15Product name120240313
c93ffd9a-5bad-44d8-b5e5-16ef4d2fee72Product name120220316
5b0ed980-56ce-7dd0-fb86-ff54be67c2e6Product name220200925
eed31638-1288-4eb6-a55c-5fc014dca98dProduct name320200728
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
a5070875-62bb-61e1-fd46-8f7054197a40Product name820180215
0add4de9-d152-3375-3390-1123dddc5e3dProduct name120140508
33ca0fcc-1011-92dc-50a9-a383683eed1eProduct name120140508
53f39d9f-cd3f-04e1-c668-d4580719d57dProduct name120140508
a804000f-b74f-0b5d-d17b-aa767c286ddbProduct name120140508
a91ea265-6e02-c08f-93c8-686d54180529Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-1028-22021-01-29C16284748780-1ba0f9c33-44d9-a910-e053-dadaa90a0b85BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-1028-2BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%30 g in 1 BOTTLE, PUMPGEL301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-1028BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190516_88f00580-a0c9-168f-e053-2a95a90a6e4b.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
72934-1028-27293410280230 g in 1 BOTTLE, PUMP30 gHistorical